Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
Keyword(s):
2021 ◽
pp. 188587
Keyword(s):
2007 ◽
Vol 121
(7)
◽
pp. 1433-1444
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 26
(4)
◽
pp. 530-537
◽
Keyword(s):
2012 ◽
Keyword(s):
2013 ◽